• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超多发原发性肺癌在丝裂原活化蛋白激酶(MAPK)通路中存在高频BRAF突变和低频表皮生长因子受体(EGFR)突变。

Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathway.

作者信息

Li Haochen, Huang Zhicheng, Guo Chao, Wang Yadong, Li Bowen, Wang Sha, Bai Na, Chen Hanlin, Xue Jianchao, Wang Daoyun, Zheng Zhibo, Bing Zhongxing, Song Yang, Xu Yuan, Huang Guanghua, Yu Xiaoqing, Li Ruirui, Fung Ka Luk, Li Ji, Song Lan, Zhu Ziwei, Liu Songtao, Liang Naixin, Li Shanqing

机构信息

Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

School of Medicine, Tsinghua University, Beijing, 100084, China.

出版信息

NPJ Precis Oncol. 2024 Oct 9;8(1):229. doi: 10.1038/s41698-024-00726-3.

DOI:10.1038/s41698-024-00726-3
PMID:39384982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11464572/
Abstract

The incidence of multiple primary lung cancer (MPLC) is increasing, with some of our surgical patients exhibiting numerous lesions. We defined lung cancer with five or more primary lesions as super MPLCs. Elucidating the genomic characteristics of this special MPLC subtype can help reduce disease burden and understand tumor evolution. In our cohort of synchronous super early-stage MPLCs (PUMCH-ssesMPLC), whole-exome sequencing on 130 resected malignant specimens from 18 patients provided comprehensive super-MPLC genomic landscapes. Mutations are enriched in PI3k-Akt and MAPK pathways. Their BRAF mutation frequency (31.5%) is significantly higher than MPLC with fewer lesions and early-stage single-lesion cancer, while EGFR mutations are significantly fewer (13.8%). As lesion counts increase, BRAF mutations gradually become dominant. Also, invasive lesions more tend to have classic super-MPLC mutation patterns. High-frequency BRAF mutations, especially Class II, and low-frequency EGFR mutations could be a reason for the limited effectiveness of targeted therapy in super-MPLC patients.

摘要

多原发性肺癌(MPLC)的发病率正在上升,我们的一些手术患者表现出大量病灶。我们将具有五个或更多原发性病灶的肺癌定义为超级MPLC。阐明这种特殊MPLC亚型的基因组特征有助于减轻疾病负担并了解肿瘤演变。在我们的同步超早期MPLC队列(PUMCH-ssesMPLC)中,对18例患者的130份切除的恶性标本进行全外显子组测序,提供了全面的超级MPLC基因组图谱。突变在PI3k-Akt和MAPK途径中富集。它们的BRAF突变频率(31.5%)显著高于病灶较少的MPLC和早期单病灶癌,而EGFR突变显著较少(13.8%)。随着病灶数量的增加,BRAF突变逐渐占主导地位。此外,侵袭性病灶更倾向于具有典型的超级MPLC突变模式。高频BRAF突变,尤其是II类,以及低频EGFR突变可能是超级MPLC患者靶向治疗效果有限的一个原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/a82cb16db3f2/41698_2024_726_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/bd9d1f00758d/41698_2024_726_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/3ad9ea6b6f42/41698_2024_726_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/e5efe9dfc0f9/41698_2024_726_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/3fe5871faf9c/41698_2024_726_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/a82cb16db3f2/41698_2024_726_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/bd9d1f00758d/41698_2024_726_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/3ad9ea6b6f42/41698_2024_726_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/e5efe9dfc0f9/41698_2024_726_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/3fe5871faf9c/41698_2024_726_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63a5/11464572/a82cb16db3f2/41698_2024_726_Fig5_HTML.jpg

相似文献

1
Super multiple primary lung cancers harbor high-frequency BRAF and low-frequency EGFR mutations in the MAPK pathway.超多发原发性肺癌在丝裂原活化蛋白激酶(MAPK)通路中存在高频BRAF突变和低频表皮生长因子受体(EGFR)突变。
NPJ Precis Oncol. 2024 Oct 9;8(1):229. doi: 10.1038/s41698-024-00726-3.
2
Clinical and genetic characteristics of early-stage multiple primary and independent primary lung adenocarcinoma patients.早期多原发和独立原发性肺腺癌患者的临床和遗传特征。
Asia Pac J Clin Oncol. 2022 Oct;18(5):e420-e426. doi: 10.1111/ajco.13743. Epub 2022 Jan 30.
3
The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients.基于大panel二代测序(NGS)检测的多原发性肺癌(MPLC)患者独特基因突变特征
Discov Med. 2023 Apr;35(175):131-143. doi: 10.24976/Discov.Med.202335175.14.
4
Genomic characteristics and immune landscape of super multiple primary lung cancer.超级多发原发性肺癌的基因组特征和免疫景观。
EBioMedicine. 2024 Mar;101:105019. doi: 10.1016/j.ebiom.2024.105019. Epub 2024 Feb 15.
5
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.同步性多原发肺癌的基因组图谱及其与 TMB、PD-L1 表达和免疫细胞浸润图谱的关联。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003773.
6
Presentation of mutations in 162 family probands with multiple primary lung cancer.162例多原发性肺癌家族先证者的突变情况
Transl Lung Cancer Res. 2021 Apr;10(4):1734-1746. doi: 10.21037/tlcr-20-1001.
7
Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma.下一代测序在同步多灶性肺腺癌诊断中的遗传特征及应用价值
Oncol Lett. 2020 Sep;20(3):2829-2839. doi: 10.3892/ol.2020.11843. Epub 2020 Jul 9.
8
Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report.从不吸烟者中含有离散驱动基因突变的同步原发性肺癌:病例报告
Case Rep Oncol. 2023 Nov 14;16(1):1384-1389. doi: 10.1159/000533892. eCollection 2023 Jan-Dec.
9
Use of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience.多原发肺癌分期中致癌驱动基因突变的应用:单中心经验。
J Thorac Oncol. 2017 Oct;12(10):1524-1535. doi: 10.1016/j.jtho.2017.06.012. Epub 2017 Jun 21.
10
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.克隆性扩展的共享 T 细胞受体揭示了同步多原发性肺癌不同病变之间存在免疫共性。
Cancer Immunol Immunother. 2024 Apr 26;73(6):111. doi: 10.1007/s00262-024-03703-8.

本文引用的文献

1
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.克隆性扩展的共享 T 细胞受体揭示了同步多原发性肺癌不同病变之间存在免疫共性。
Cancer Immunol Immunother. 2024 Apr 26;73(6):111. doi: 10.1007/s00262-024-03703-8.
2
Genomic characteristics and immune landscape of super multiple primary lung cancer.超级多发原发性肺癌的基因组特征和免疫景观。
EBioMedicine. 2024 Mar;101:105019. doi: 10.1016/j.ebiom.2024.105019. Epub 2024 Feb 15.
3
Deterministic evolution and stringent selection during preneoplasia.
癌前病变过程中的确定性进化和严格选择。
Nature. 2023 Jun;618(7964):383-393. doi: 10.1038/s41586-023-06102-8. Epub 2023 May 31.
4
Multiple primary lung cancer: Updates of clinical management and genomic features.多原发性肺癌:临床管理与基因组特征的更新
Front Oncol. 2023 Feb 22;13:1034752. doi: 10.3389/fonc.2023.1034752. eCollection 2023.
5
Lack of evolutionary convergence in multiple primary lung cancer suggests insufficient specificity of personalized therapy.多种原发性肺癌中缺乏进化趋同表明个体化治疗的特异性不足。
J Genet Genomics. 2023 May;50(5):330-340. doi: 10.1016/j.jgg.2022.11.005. Epub 2022 Nov 19.
6
Comprehensive characterization of genomic and radiologic features reveals distinct driver patterns of RTK/RAS pathway in ground-glass opacity pulmonary nodules.全面的基因组和影像学特征分析揭示了磨玻璃密度肺结节中 RTK/RAS 通路的不同驱动模式。
Int J Cancer. 2022 Dec 1;151(11):2020-2030. doi: 10.1002/ijc.34238. Epub 2022 Aug 27.
7
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.通过对手术切除的肺腺癌进行全面分析,确定了浸润前和浸润性亚型之间的独特突变特征。
Mod Pathol. 2022 Sep;35(9):1181-1192. doi: 10.1038/s41379-022-01076-w. Epub 2022 May 31.
8
Stepwise evolutionary genomics of early-stage lung adenocarcinoma manifesting as pure, heterogeneous and part-solid ground-glass nodules.早期肺腺癌呈纯磨玻璃、混杂性和部分实性磨玻璃结节表现的逐步进化基因组学。
Br J Cancer. 2022 Sep;127(4):747-756. doi: 10.1038/s41416-022-01821-7. Epub 2022 May 26.
9
Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer.表皮生长因子受体(EGFR)相关的丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)通路在多原发性肺癌中的临床意义
Clin Transl Med. 2022 May;12(5):e847. doi: 10.1002/ctm2.847.
10
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.同步性多原发肺癌的基因组图谱及其与 TMB、PD-L1 表达和免疫细胞浸润图谱的关联。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003773.